Brief: Caribou Biosciences Announces The FDA Granted Regenerative Medicine Advanced Therapy (Rmat) Designation To Cb-011
31/03/2026 13:39
March 31 (Reuters) - Caribou Biosciences Inc CRBU.O: CARIBOU BIOSCIENCES ANNOUNCES THE FDA GRANTED REGENERATIVE MEDICINE ADVANCED THERAPY (RMAT) DESIGNATION TO CB-011, AN ALLOGENEIC ANTI-BCMA CAR-T CELL THERAPY Source text: ID:nGNX5LmW4N Further company coverage: CRBU.O ((Reuters.Briefs@thomsonreuters.com;))